Results 251 to 260 of about 49,783 (286)

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

, 2017
Mayer Srour, Agnès Glacet, Jean‐François Girmens, Laurent Kodjikian, Cécile Delcourt, F. Fajnkuchen, Catherine P. Creuzot Garcher, Pascale Massin, Pierre-Jean Guillausseau, Anne Ponthieux, Laetitia Finzi, Angela Grelaud-Boussinot, Bpe Team   +12 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Risk factors in central retinal vein occlusion: A multi-center case-control study conducted on the Italian population

European Journal of Ophthalmology, 2021
Purpose To explore the risk factors for central retinal vein occlusion (CRVO) by comparing a large sample of patients with healthy controls. Materials and Methods Multi-center case-control study.
E. Trovato Battagliola, F. Pacella, M. Malvasi, S. Z. Scalinci, P. Turchetti, E. Pacella, Giuseppe La Torre, Loredana Arrico   +7 more
semanticscholar   +1 more source

Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19)

Ocular immunology and inflammation, 2020
Purpose To report a case of impending central retinal vein occlusion (iCRVO) in a COVID-19 patient. Case Report A 54 years old woman with COVID-19 related pneumonia presented to our emergency department complaining of scotomas and decreased vision in her
A. Invernizzi, M. Pellegrini, D. Messenio, M. Cereda, Pietro Olivieri, A. Brambilla, G. Staurenghi   +6 more
semanticscholar   +1 more source

CENTRAL RETINAL VEIN OCCLUSION FOLLOWING BNT162B2 (PFIZER-BIONTECH) COVID-19 MESSENGER RNA VACCINE

Retinal cases & brief reports, 2021
A 27-year-old woman was found to have central retinal vein occlusion a few days after her first dose of the BNT162b2 (Pfizer-BioNTech) coronavirus disease 2019 vaccine; worsening peripapillary hemorrhages and symptoms were noted after the second dose of ...
Paras P. Shah, Samuel Gelnick, J. Jonisch, R. Verma   +3 more
semanticscholar   +1 more source

Risk factors for central retinal vein occlusion in young adults

European Journal of Ophthalmology, 2020
Purpose: Several risk factors have been identified for central retinal vein occlusion (CRVO) in older population. CRVO in young is uncommon, and the risk factors for this group are unclear.
Tony Y. Chen, Aditya Uppuluri, M. Zarbin, N. Bhagat   +3 more
semanticscholar   +1 more source

INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial.

Retina, 2019
PURPOSE To prospectively investigate the injection frequency of aflibercept and ranibizumab in the treatment of macular edema in central retinal vein occlusion. METHODS Patients with treatment-naive central retinal vein occlusion and macular edema were
Manuel Casselholm de Salles, Urban Amrén, A. Kvanta, David Epstein   +3 more
semanticscholar   +1 more source

EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study

Retina, 2018
Purpose: To quantitatively assess macular perfusion status using optical coherence tomography angiography in eyes with aflibercept-treated central retinal vein occlusion and resolved macular edema and to investigate the impact of macular morphology and ...
Rima Ghashut, Yuki Muraoka, S. Ooto, Yuto Iida, Yuko Miwa, K. Suzuma, T. Murakami, S. Kadomoto, A. Tsujikawa, N. Yoshimura   +9 more
semanticscholar   +1 more source

LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE

Retina, 2017
Purpose: To investigate whether the results of early tests for hypercoagulability are correlated with the development of central retinal vein occlusion risk factors later in life and to evaluate the necessity of these tests in younger patients.
Qingyun Liu, J. Lahey, Rachel Karlen, Jay M. Stewart   +3 more
semanticscholar   +1 more source

RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study

Retina, 2017
Purpose: To investigate vascular perfusion and foveal avascular zone area in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) after intravitreal aflibercept therapy in central retinal vein occlusion eyes and their association with ...
Andrew Winegarner, Taku Wakabayashi, Chikako Hara-Ueno, Tatsuhiko Sato, Caleb Busch, Yoko Fukushima, K. Sayanagi, K. Nishida, H. Sakaguchi, K. Nishida   +9 more
semanticscholar   +1 more source